Literature DB >> 28105497

Comparison of Traditional and Emerging Surgical Therapies for Lower Urinary Tract Symptoms in Men: A Review.

Christopher Smith1, Paul Craig1, Shayandokht Taleb1, Shamar Young1, Jafar Golzarian2.   

Abstract

Lower urinary tract symptoms (LUTS) are one of the most common health issues in men and pose a significant economic challenge in healthcare. Transurethral resection of the prostate (TURP) remains the gold standard surgical treatment for medically refractive LUTS secondary to benign prostatic hyperplasia. The institution of medical therapy and the development of several minimally invasive surgical therapies (MISTs) began in the 1980's and 1990's. Together, these therapies brought about a change in the natural course of the disease, stimulating investigation into the economic consequences of various management approaches. TURP has been observed to have higher complication rates, but better efficacy and lower retreatment rates compared to MISTs. Staying abreast of the evolving understanding of LUTS and the alternative treatment options is imperative for radiologists.

Entities:  

Keywords:  Benign prostatic hyperplasia; Lower urinary tract symptoms; Minimally invasive surgical therapies; Prostate; Transurethral resection of the prostate

Mesh:

Year:  2017        PMID: 28105497     DOI: 10.1007/s00270-017-1575-7

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

Review 1.  Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room.

Authors:  Bradley C Gill; James C Ulchaker
Journal:  Curr Urol Rep       Date:  2018-07-19       Impact factor: 3.092

2.  Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.

Authors:  Cosimo De Nunzio; Francesco Cantiello; Cristian Fiori; Fabio Crocerossa; Piero Tognoni; Daniele Amparore; Valeria Baldassarri; Javier Reinoso Elbers; Fernando Gomez Sancha; Francesco Porpiglia
Journal:  World J Urol       Date:  2020-08-26       Impact factor: 4.226

3.  Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis.

Authors:  B Malling; M A Røder; K Brasso; J Forman; M Taudorf; L Lönn
Journal:  Eur Radiol       Date:  2018-06-14       Impact factor: 5.315

4.  Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response.

Authors:  Marco Pandolfi; Alessandro Liguori; Martina Gurgitano; Antonio Arrichiello; Letizia Di Meglio; Giovanni Maria Rodà; Alice Guadagni; Salvatore Alessio Angileri; Anna Maria Ierardi; Giorgio Buccimazza; Daniela Donat; Aldo Paolucci; Gianpaolo Carrafiello
Journal:  Acta Biomed       Date:  2020-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.